Cargando…
Author Correction: Structure basis for inhibition of SARS-CoV-2 by the feline drug GC376
Autores principales: | Luan, Xiao-dong, Chen, Bin-xian, Shang, Wei-juan, Yin, Wan-chao, Jin, Ye, Zhang, Lei-ke, Xu, H. Eric, Zhang, Shu-yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363863/ https://www.ncbi.nlm.nih.gov/pubmed/35948753 http://dx.doi.org/10.1038/s41401-022-00964-w |
Ejemplares similares
-
Structure basis for inhibition of SARS-CoV-2 by the feline drug GC376
por: Luan, Xiao-dong, et al.
Publicado: (2022) -
Crystallization of Feline Coronavirus M(pro) With GC376 Reveals Mechanism of Inhibition
por: Lu, Jimmy, et al.
Publicado: (2022) -
Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis
por: Sharun, Khan, et al.
Publicado: (2020) -
N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 M(pro) Dimer
por: Arutyunova, Elena, et al.
Publicado: (2021) -
Improved SARS-CoV-2 M(pro) inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies
por: Vuong, Wayne, et al.
Publicado: (2021)